Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion net income
Net income is the profit left for shareholders after every expense, interest and tax.
Aclarion's net income for the twelve months ending Jun 30, 2026 was -$9.20M. For fiscal 2025 it was -$7.23M. The highest annual figure on record is -$4.91M in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.23M | – |
| FY2024 | Dec 31, 2024 | -$6.99M | – |
| FY2023 | Dec 31, 2023 | -$4.91M | – |
| FY2022 | Dec 31, 2022 | -$7.07M | – |
| FY2021 | Dec 31, 2021 | -$4.95M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.75M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.89M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.99M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.37M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.24M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.40M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.27M | – |
| Q3 FY2023 | Sep 30, 2023 | -$998.01K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.46M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.18M | – |
| Q4 FY2022 | Dec 31, 2022 | -$944.61K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.63M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.01M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.95M | – |
| Q2 FY2021 | Jun 30, 2021 | -$465.84K | – |
| Q1 FY2021 | Mar 31, 2021 | -$517.86K | – |